AU5622700A - Retro-inverso peptides derived from leukemia inhibitory factor - Google Patents

Retro-inverso peptides derived from leukemia inhibitory factor

Info

Publication number
AU5622700A
AU5622700A AU56227/00A AU5622700A AU5622700A AU 5622700 A AU5622700 A AU 5622700A AU 56227/00 A AU56227/00 A AU 56227/00A AU 5622700 A AU5622700 A AU 5622700A AU 5622700 A AU5622700 A AU 5622700A
Authority
AU
Australia
Prior art keywords
retro
peptides derived
inhibitory factor
leukemia inhibitory
inverso peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56227/00A
Other languages
English (en)
Inventor
D. Elliot Parks
David E. Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Myelos Corp
Original Assignee
Myelos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myelos Corp filed Critical Myelos Corp
Publication of AU5622700A publication Critical patent/AU5622700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5415—Leukaemia inhibitory factor [LIF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU56227/00A 1999-06-16 2000-06-16 Retro-inverso peptides derived from leukemia inhibitory factor Abandoned AU5622700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13968599P 1999-06-16 1999-06-16
US60139685 1999-06-16
PCT/US2000/016760 WO2000077029A1 (en) 1999-06-16 2000-06-16 Retro-inverso peptides derived from leukemia inhibitory factor

Publications (1)

Publication Number Publication Date
AU5622700A true AU5622700A (en) 2001-01-02

Family

ID=22487838

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56227/00A Abandoned AU5622700A (en) 1999-06-16 2000-06-16 Retro-inverso peptides derived from leukemia inhibitory factor

Country Status (6)

Country Link
EP (1) EP1183266A4 (cg-RX-API-DMAC7.html)
JP (2) JP2003502341A (cg-RX-API-DMAC7.html)
AU (1) AU5622700A (cg-RX-API-DMAC7.html)
CA (1) CA2376474A1 (cg-RX-API-DMAC7.html)
IL (2) IL147095A0 (cg-RX-API-DMAC7.html)
WO (1) WO2000077029A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
AU2001237132B2 (en) * 2000-03-03 2006-04-27 Amrad Corporation Limited A method of treatment
WO2001064239A1 (en) * 2000-03-03 2001-09-07 The Walter And Eliza Hall Institute Of Medical Research A method of treatment
WO2007112566A1 (en) * 2006-03-31 2007-10-11 Queen's University At Kingston Compositions and methods for treating atherosclerosis
IL255697B2 (en) 2015-05-18 2023-11-01 Tcr2 Therapeutics Inc Compositions and methods for TCR programming using fusion proteins
AU2017363311A1 (en) 2016-11-22 2019-06-13 TCR2 Therapeutics Inc. Compositions and methods for TCR reprogramming using fusion proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843892A (en) * 1989-12-18 1998-12-01 California Institute Of Technology Stimulation of nerve growth and/or vitality
US5700909A (en) * 1993-07-30 1997-12-23 The Regents Of The University Of California Prosaposin and cytokine-derived peptides
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
EP0979238A4 (en) * 1997-03-05 2000-08-23 Univ California METHOD FOR HEALING NEUROPATHIC PAIN
US6458357B1 (en) * 1997-09-09 2002-10-01 Myelos Corporation Retro-inverso neurotrophic and analgesic peptides

Also Published As

Publication number Publication date
CA2376474A1 (en) 2000-12-21
WO2000077029A1 (en) 2000-12-21
EP1183266A1 (en) 2002-03-06
JP2003502341A (ja) 2003-01-21
EP1183266A4 (en) 2002-10-23
IL147095A (en) 2010-12-30
IL147095A0 (en) 2002-08-14
JP2011144184A (ja) 2011-07-28

Similar Documents

Publication Publication Date Title
AU4230896A (en) Cancer inhibitory peptides
AU2196101A (en) Complementary peptide ligands generated from the human genome
AU2719500A (en) Seed-preferred promoter
AU2495300A (en) Lentivirus vector system
AU2002252801A1 (en) Peptides derived from colostrinin
AUPO026596A0 (en) Viral peptide
WO2003045973A8 (en) Peptides with growth inhibitory action
AU5622700A (en) Retro-inverso peptides derived from leukemia inhibitory factor
AU2002243639A1 (en) Supplemental bilge filtraton system
AU2973100A (en) Novel agouti and agouti-related peptide analogs
EP1253928A4 (en) NEW HAPTOTACTIC PEPTIDES
AU2691500A (en) Novel polypeptide
AU5496500A (en) Retro-inverso peptides derived from interleukin-3
HK1042713A (en) Retro-inverso peptides derived from leukemia inhibitory factor
AU2001287178A1 (en) Antimicrobial peptides isolated from mast cells
AU2002222471A1 (en) Inhibitory agents derived from specific growth factors
AU3086301A (en) Epididymal antimicrobial peptides
AU4778600A (en) Novel polypeptide
AU6540500A (en) Retro-inverso peptides derived from interleukin-6
AU1552800A (en) Coupled peptides
HK1042712A (en) Retro-inverso peptides derived from interleukin-6
AUPQ386899A0 (en) Peptide compounds
HK1042711A (en) Retro-inverso peptides derived from interleukin-3
AU2109200A (en) Polypeptide
AU2603100A (en) Novel hiv related peptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase